Login

Business Growth Plans: Diversifying Product Lines and Strengthening Technology Integration|Dhiraj Patel,Managing Director,Vikram Thermo (India) Ltd. 00:10:00

Share On Facebook Share On Twitter

Dhiraj Patel,Chaiman and Managing Director

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Insights into Lindsell Train's Global Equity Fund with Michael Lintzel: Philosophy, Strategy, and Performance | Michael Lindsell , Co-founder ,  Lindsell Train.
00:10:00
Richard Hormann at Excelerate Energy explains how the company facilitated consistent power supply to Bangladesh, with support from Capgemini, leveraging innovative solutions in energy infrastructure.
00:10:00
Magnetic Resource: Exploring Major Gold Potential in Laverton
00:10:00
Market Updates: AI Insights and Portfolio Adjustments | Jim Evans, Co-Founder , TTG Financial Inc.
00:10:00
"Jean Raby, Head of Asset & Wealth Management at Natixis, highlights their distinctive model, merging active investment teams' agility with a centralized distribution network."|Philippe Setbon is Chief Executive Officer for Natixis Investment Managers.
00:10:00
Glenn August, Oak Hill Advisors CEO, Discusses $5 Billion Credit Investment Strategy | Glenn August, CEO, Oak Hill Advisors.
00:10:00
USV invests at the edge of large markets being transformed by technological and societal pressures|Fred Wilson, Investor, Union Square Ventures
00:10:00
Transitioning from IV infusions to subcutaneous injections can indeed make a significant difference in patient comfort and convenience|Lynn Hartung,President,Qprotyn
00:10:00
"Investing Explained: Navigating Funds with Consultant Henry Cobbe"
00:10:00
Dennis Calvert, President & CEO of BioLargo, Inc., Leads Innovation in Sustainable Technologies | Dennis Calvert , CEO, BioLargo Inc.
00:00:00
Eric A. Adams, MIBS Chief Executive Officer & President, InMed Pharmaceuticals Inc
00:10:00
Experience the Drillmore difference| Babak Bemani , Chief Executive Officer at Drillmore

© 2026 Nehu